NASDAQ · KMB
Consumer Defensive · Household & Personal Products
$98.68
Down-$0.42 (-0.42%)
Updated Sep 16, 2026, 9:45 AM
SID Score
5.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 20 trading sessions · Daily adjusted prices
KMB closed at $98.68 after 20 trading sessions, down 8.40% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $98.345 | $98.815 | $97.19 | $98.675 | 6.66M |
| Sep 14, 2026 | $99.18 | $100.9199 | $98.98 | $99.09 | 6.38M |
| Sep 11, 2026 | $99.24 | $99.52 | $97.295 | $98.15 | 8.14M |
| Sep 10, 2026 | $98.725 | $99.54 | $98.275 | $98.48 | 9.88M |
| Sep 9, 2026 | $100.995 | $100.995 | $97.91 | $98.70 | 6.96M |
| Sep 8, 2026 | $104.55 | $104.70 | $102.81 | $102.93 | 3.3M |
| Sep 4, 2026 | $106.505 | $106.93 | $104.85 | $104.96 | 4.15M |
| Sep 3, 2026 | $109.75 | $110.00 | $107.495 | $107.95 | 3.2M |
| Sep 2, 2026 | $107.47 | $109.41 | $106.92 | $109.29 | 3.95M |
| Sep 1, 2026 | $108.00 | $108.89 | $106.7601 | $107.08 | 3.62M |
| Aug 31, 2026 | $108.93 | $109.4377 | $107.41 | $107.95 | 4.49M |
| Aug 28, 2026 | $110.95 | $111.39 | $109.52 | $109.55 | 2.43M |
| Aug 27, 2026 | $109.12 | $110.32 | $108.61 | $109.98 | 3.34M |
| Aug 26, 2026 | $111.74 | $111.84 | $110.25 | $110.34 | 3.95M |
| Aug 25, 2026 | $111.065 | $111.22 | $109.83 | $111.02 | 2.81M |
| Aug 24, 2026 | $109.90 | $112.38 | $109.87 | $111.37 | 2.69M |
| Aug 21, 2026 | $108.88 | $109.8825 | $108.07 | $109.31 | 2.1M |
| Aug 20, 2026 | $109.39 | $110.00 | $108.09 | $108.69 | 2.43M |
| Aug 19, 2026 | $108.86 | $110.10 | $108.33 | $109.88 | 3.67M |
| Aug 18, 2026 | $108.83 | $109.79 | $107.66 | $107.72 | 2.39M |
The latest Smart Investors Daily articles mentioning KMB.
KMB research
Company profile and research snapshot.
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It intends to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | Piper Sandler | Overweight | — |
| Sep 10, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 5, 2026 | UBS | Neutral | — |
| Aug 5, 2026 | TD Cowen | Hold | — |
| Jul 21, 2026 | Barclays | Equal-Weight | — |
No generated briefing is available yet.
Yahoo · Sep 12, 2026
Kimberly-Clark just raised its dividend for the 54th straight year while simultaneously chasing a nearly $50 billion acquisition, and income investors are now weighing whether a deal of that size can coexist with a payout that costs over $1.6 billion annually.
Benzinga · Sep 11, 2026
Piper Sandler analyst Michael Lavery maintains Kimberly-Clark (NASDAQ:KMB) with a Overweight and lowers the price target from $121 to $118.
Benzinga · Sep 10, 2026
Wells Fargo analyst Chris Carey maintains Kimberly-Clark (NASDAQ:KMB) with a Equal-Weight and lowers the price target from $110 to $105.
SeekingAlpha · Sep 9, 2026
Kimberly-Clark Corporation (KMB) Barclays 19th Annual Global Consumer Staples Conference September 9, 2026 7:30 AM EDTCompany ParticipantsMichael Hsu -...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning KMB.
